Alessandro Bonifazi

32PUBLICATIONS
67CO-AUTHORS
Molecular targetsBiomolecular modelling and designPharmacogenomicsBiologically active moleculesInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 13, 2026
Probing chemical space and conformational changes for subtype-selective orexin receptor antagonists.

|Jul 30, 2026
A Ligand-Triggered Receptor Conformation Enables the Design of Selective Agonists for the Dopamine 3 Receptor (D3R) Using a Bitopic Strategy.

|Jul 08, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

|Feb 06, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids.

Morena Miciaccia, Domenico Armenise, Olga Maria Baldelli

|Nov 29, 2025
Structure-Function Activity Relationships of Cariprazine Analogues with Distinct G Protein versus β-Arrestin Activities at the Dopamine D3 Receptor.

Bradley M Keegan, Caleb D Vogt, Li Chen

|Mar 29, 2025
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.

Federica Matteucci, Pegi Pavletić, Alessandro Bonifazi

Pageof 6

Frequent Collaborators

18 joint publications

Amy Hauck Newman

9 joint publications

Fabio Del Bello

7 joint publications

Gianfabio Giorgioni

7 joint publications

Wilma Quaglia